
|Articles|January 1, 2018
- Pharmaceutical Executive-01-01-2018
- Volume 38
- Issue 1
Pharmaceutical Executive, January 2018 Issue (PDF)
Click the title above to open the Pharmaceutical Executive January 2018 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 8 years ago
Changing Skies: Pharm Exec’s 2018 Industry Forecastover 8 years ago
Q&A: From Gleevec to CAR-Tover 8 years ago
Prices and Competition to Shape the Year Aheadover 8 years ago
CAR-T Concerns for Continued Successover 8 years ago
New Year, Next Steps in Digital Transformationover 8 years ago
Food for Thought in Cancer Fightover 8 years ago
Parting Arrangementsover 8 years ago
Country Report: SwitzerlandAdvertisement
Advertisement
Advertisement
Trending on PharmExec
1
Trump Administration Preparing New Round of Medicaid Drug-Pricing Deals: Report
2
Study Shows Link Between Zepbound and Lower Healthcare Costs in Adults Aged 55 and Up with Obesity: Report
3
Pharmaceutical Executive Daily: DualityBio and Teva Strike Major Biopharma Deals
4
M&A Roundup: DualityBio & Genentech Enter Partnership to Develop Next Generation ADC’s, Teva Bids to Acquire Igalmi from BioXcel
5




